Studying Tumor Tissue Samples From Patients With Early-Stage Breast Cancer
NCT00899639 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2015-05-29
Summary
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This research study is looking at tumor tissue samples from patients with early-stage breast cancer.
Conditions
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Rutgers Cancer Institute of New Jersey
collaborator OTHER -
Rutgers, The State University of New Jersey
lead OTHER
Principal Investigators
-
Shridar Ganesan, MD · Rutgers Cancer Institute of New Jersey
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-05-31
- Primary Completion
- 2008-05-31
- Completion
- 2008-05-31
More Related Trials
-
Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer
NCT00089323 ·Status: COMPLETED ·Phase: NA
-
Molecular and Cellular Analysis of Breast Cancer
NCT02243397 ·Status: COMPLETED
-
Genetic and Protein Profiling in Normal and Cancerous Breast Tissue
NCT00083733 ·Status: COMPLETED
-
Study of Biomarkers in Tissue Samples From Patients With Breast Cancer
NCT01004796 ·Status: UNKNOWN
-
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
NCT01000883 ·Status: RECRUITING
-
Study of Breast Tissue in Women Not Previously Diagnosed With Breast Cancer Who Are Undergoing Fine Needle Aspiration
NCT00896636 ·Status: UNKNOWN
-
Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy
NCT01568346 ·Status: TERMINATED ·Phase: PHASE3
-
Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
NCT00898508 ·Status: COMPLETED
-
Molecular Analysis of Breast Cancer
NCT00569049 ·Status: COMPLETED
-
Studying Blood Samples in Women With Breast Cancer or a History of Breast Cancer
NCT00898703 ·Status: COMPLETED
-
Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy
NCT00897299 ·Status: COMPLETED
-
Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer
NCT00897416 ·Status: COMPLETED
-
Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer
NCT02127073 ·Status: TERMINATED ·Phase: PHASE2
-
Assessment of Candidate Protein Expression in Breast Cancer Specimens
NCT00918892 ·Status: COMPLETED
-
Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease
NCT00813878 ·Status: TERMINATED
-
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery
NCT03188393 ·Status: COMPLETED ·Phase: PHASE2
-
Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer
NCT00588029 ·Status: ACTIVE_NOT_RECRUITING
-
Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer
NCT00897208 ·Status: COMPLETED
-
Tissue Procurement Protocol for Patients Undergoing Treatment for Early-Stage Breast Cancer
NCT02455882 ·Status: TERMINATED
-
SWOG 8897-A DNA Analysis in Predicting Treatment Outcome in Women With Breast Cancer in SWOG 8897
NCT00896623 ·Status: COMPLETED
-
Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer
NCT02530008 ·Status: ACTIVE_NOT_RECRUITING
-
Lymph Fluid and Blood Collection for Identification of Novel Biomarkers
NCT01075607 ·Status: TERMINATED
-
Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer
NCT00766454 ·Status: COMPLETED
-
Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery
NCT00033397 ·Status: COMPLETED
-
Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
NCT00899145 ·Status: WITHDRAWN